Lantern Pharma Reports Third Quarter 2026 Financial Results and Provides Business Updates
Lantern Pharma Inc. (NASDAQ:LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced operational…